Acadia

This page shows the latest Acadia news and features for those working in and with pharma, biotech and healthcare.

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug. Concludes Acadia Pharmaceuticals’ drug provides ‘ modest but meaningful’ benefits. ... Acadia Pharmaceuticals is celebrating an FDA panel verdict that could set its Nuplazid

Latest news

Acadia shares increase as pimavanserin clears phase III trial

Acadia shares increase as pimavanserin clears phase III trial. Demonstrated to reduce psychotic symptoms. ... They also suggest that Acadia may now move quickly ahead with trying to find a marketing partner for pimavanserin outside the US.
This month in 1901: Birth of Charles Brenton Huggins

Born in Novia Scotia on September 22, 1901, Huggins was educated at the region's Acadia University, before spending time at Harvard Medical School and then the University of Michigan where
Clouded vision

AGN· 203818 is an orally active, α-adrenoreceptor agonist that was discovered as part of a research programme between Allergan and ACADIA.
Striking a balance

Xsira Pharmaceuticals, 7TM Pharma, Acadia Pharmaceuticals, Glenmark Pharmaceuticals, Esteve, Vernalis, OSI Pharmaceuticals, EPIX Pharmaceuticals, Bayer and Novasite Pharmaceuticals are all undertaking separate research projects to develop CB1
Thomson Scientific publishes quarterly review of phase changes in industry pipeline

Compound. Indication. Company. trazodone. Depression. Labopharm. pimavanserin. Schizophrenia. Acadia Pharmaceuticals. salmon calcitonin.

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest appointments

Damien McDevitt moves from GSK to Acadia Pharmaceuticals

US biopharmaceutical company Acadia Pharmaceuticals has appointed Damien McDevitt (pictured) as senior vice president of corporate development. ... Meanwhile, Acadia’s SVP, technology development and operations Jim Nash will retire in January.
Juniper Pharmaceuticals adds to board of directors

Dr Gray has over 20 years of biotechnology and biopharmaceutical experience and is the owner and president of Gray Strategic Advisors as well as serving on the boards of Acadia Pharmaceuticals,
Srdjan Stankovic joins Acadia Pharmaceuticals

Srdjan Stankovic joins Acadia Pharmaceuticals. He moves to the San Diego biopharma from Alkermes. ... Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Medical Writer: Great salary and benefits

Editorial Director – Medical Education – Oxford: Negotiable

Senior Medical Writer: Great salary and bebefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Scientific Director: Great salary and bebefits

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Account Manager / Account Director: Great salary and bebefits

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Programme Executive: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Account Manager or AD - Medical Communications: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...